Cost-Effectiveness of Drug-Eluting Stents for Infrapopliteal Lesions in Patients with Critical Limb Ischemia: The PADI Trial
Sign Up to like & getrecommendations! Published in 2019 at "CardioVascular and Interventional Radiology"
DOI: 10.1007/s00270-019-02385-5
Abstract: Purpose Drug-eluting stents (DES) improve clinical and morphological long-term results compared to percutaneous transluminal angioplasty (PTA) with bailout bare metal stenting (BMS) in patients with critical limb ischemia (CLI) and infrapopliteal lesions (PADI trial). We… read more here.
Keywords: trial; year; padi trial; infrapopliteal lesions ... See more keywords
10-Year Paclitaxel Dose-Related Outcomes of Drug-Eluting Stents Treated Below the Knee in Patients with Chronic Limb-Threatening Ischemia (The PADI Trial)
Sign Up to like & getrecommendations! Published in 2020 at "Cardiovascular and Interventional Radiology"
DOI: 10.1007/s00270-020-02602-6
Abstract: Recently, two meta-analyses concluded that there appears to be an increased risk of long-term mortality of paclitaxel-coated balloons and stents in the superficial femoral and popliteal artery, and paclitaxel-coated balloons below the knee. In this… read more here.
Keywords: trial; padi trial; mortality; paclitaxel coated ... See more keywords